Clinical Trials

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allard, R.
Right arrow Articles by Boivin, J.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allard, R.
Right arrow Articles by Boivin, J.-F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Trials, Vol. 4, No. 6, 611-620 (2007)
DOI: 10.1177/1740774507085279
© 2007 The Society for Clinical Trials

Using causal models to show the effect of untestable assumptions on effect estimates in randomized controlled trials

Robert Allard

Regional Health Agency, Montreal, Quebec, Canada, Joint Departments of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada, rallard{at}santepub-mtl.qc.ca

Jean-François Boivin

Joint Departments of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada

Background The methods by which randomized controlled trials (RCTs) are analyzed rest on several assumptions, most of which are untestable.

Purpose To show how estimates of the net effect of treatment on survival can be obtained requiring only the assumption that randomization produced equivalent groups.

Methods The assumptions underlying ratio measures of effect, based on disease occurrence times (DOT) obtained from survival curves, are identified and cumulatively removed.

Results The four assumptions usually made are that (1) the ratio of disease incidence rates under treatment and under reference exposure is constant over time, (2) the groups being compared are exchangeable (equivalent), (3) a subject's DOT under treatment is independent of what his DOT would have been under the reference exposure, and (4) the treatment effect, if any, is in the same direction in all subjects. Removing Assumption 4 leads to an estimator of effect resembling the etiologic fraction, but able to accommodate both causative and preventive effects. Removing all assumptions but that of exchangeability still permits the estimation, directly from the survival curves, of a range of effect magnitudes, causative or preventive, compatible with the observed DOTs. The exchangeability assumption is the easiest to meet, by randomizing enough subjects.

Limitations The statistical uncertainty that affects the estimates of survival probabilities has been ignored. Taking uncertainty into account further widens the range of effects compatible with the observations.

Conclusions Retaining only the exchangeability assumption allows for a range of possible treatment effects to be estimated, although it may be wide. Readers of RCT reports should understand that the determination of a point estimate of effect within this range is entirely a function of unverifiable analytic assumptions. Clinical Trials 2007; 4: 611—620. http://ctj.sagepub.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?